Review



chromatographically purified ivig product privigen  (CSL Behring)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    CSL Behring chromatographically purified ivig product privigen
    Original and modified processes for the manufacture of the intravenous immunoglobulin <t>product,</t> <t>Privigen.</t> a When assessing the clearance of immunoglobulin M isoagglutinins by the anion-exchange chromatography and immunoaffinity chromatography steps, the process steps outlined in orange (ethanol- and octanoic acid fractionation) were omitted to minimize the loss of immunoglobulin M, and therefore the loss of the immunoglobulin M isoagglutinins. This was done because the octanoic acid fractionation step is the main elimination step of total immunoglobulin M. The intention was to retain as much immunoglobulin M as possible for the subsequent isoagglutinin removal steps. AIC immunoaffinity chromatography, AIEX anion exchange chromatography, DF diafiltration, UF ultrafitration. Adapted with permission from Hoefferer et al. © 2015 AABB. Hoefferer L, Glauser I, Gaida A, Willimann K, Marques Antunes A, Siani B, et al. Isoagglutinin reduction by a dedicated immunoaffinity chromatography step in the manufacturing process of human immunoglobulin products. Transfusion. 2015;55(Suppl 2):S117–21. doi:10.1111/trf.13088
    Chromatographically Purified Ivig Product Privigen, supplied by CSL Behring, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/chromatographically+purified+ivig+product+privigen/chromatographically+purified+ivig+product+privigen/pmc05054059-58-10-15
    Average 90 stars, based on 1 article reviews
    chromatographically purified ivig product privigen - by Bioz Stars, 2026-09
    90/100 stars

    Images

    1) Product Images from "Reduction of Isoagglutinin in Intravenous Immunoglobulin (IVIG) Using Blood Group A- and B-Specific Immunoaffinity Chromatography: Industry-Scale Assessment"

    Article Title: Reduction of Isoagglutinin in Intravenous Immunoglobulin (IVIG) Using Blood Group A- and B-Specific Immunoaffinity Chromatography: Industry-Scale Assessment

    Journal: Biodrugs

    doi: 10.1007/s40259-016-0192-3

    Original and modified processes for the manufacture of the intravenous immunoglobulin product, Privigen. a When assessing the clearance of immunoglobulin M isoagglutinins by the anion-exchange chromatography and immunoaffinity chromatography steps, the process steps outlined in orange (ethanol- and octanoic acid fractionation) were omitted to minimize the loss of immunoglobulin M, and therefore the loss of the immunoglobulin M isoagglutinins. This was done because the octanoic acid fractionation step is the main elimination step of total immunoglobulin M. The intention was to retain as much immunoglobulin M as possible for the subsequent isoagglutinin removal steps. AIC immunoaffinity chromatography, AIEX anion exchange chromatography, DF diafiltration, UF ultrafitration. Adapted with permission from Hoefferer et al. © 2015 AABB. Hoefferer L, Glauser I, Gaida A, Willimann K, Marques Antunes A, Siani B, et al. Isoagglutinin reduction by a dedicated immunoaffinity chromatography step in the manufacturing process of human immunoglobulin products. Transfusion. 2015;55(Suppl 2):S117–21. doi:10.1111/trf.13088
    Figure Legend Snippet: Original and modified processes for the manufacture of the intravenous immunoglobulin product, Privigen. a When assessing the clearance of immunoglobulin M isoagglutinins by the anion-exchange chromatography and immunoaffinity chromatography steps, the process steps outlined in orange (ethanol- and octanoic acid fractionation) were omitted to minimize the loss of immunoglobulin M, and therefore the loss of the immunoglobulin M isoagglutinins. This was done because the octanoic acid fractionation step is the main elimination step of total immunoglobulin M. The intention was to retain as much immunoglobulin M as possible for the subsequent isoagglutinin removal steps. AIC immunoaffinity chromatography, AIEX anion exchange chromatography, DF diafiltration, UF ultrafitration. Adapted with permission from Hoefferer et al. © 2015 AABB. Hoefferer L, Glauser I, Gaida A, Willimann K, Marques Antunes A, Siani B, et al. Isoagglutinin reduction by a dedicated immunoaffinity chromatography step in the manufacturing process of human immunoglobulin products. Transfusion. 2015;55(Suppl 2):S117–21. doi:10.1111/trf.13088

    Techniques Used: Modification, Chromatography, Fractionation, Diafiltration Assay

    Anti-A and anti-B titers in intravenous immunoglobulin lots produced with the immunoaffinity chromatography step (Privigen) and intravenous immunoglobulin lots produced using Cohn-like fractionation (Sandoglobulin/Carimune), measured by the European Pharmacopoeia direct method. IAC immunoaffinity chromatography, IgG immunoglobulin G, IVIG intravenous immunoglobulin
    Figure Legend Snippet: Anti-A and anti-B titers in intravenous immunoglobulin lots produced with the immunoaffinity chromatography step (Privigen) and intravenous immunoglobulin lots produced using Cohn-like fractionation (Sandoglobulin/Carimune), measured by the European Pharmacopoeia direct method. IAC immunoaffinity chromatography, IgG immunoglobulin G, IVIG intravenous immunoglobulin

    Techniques Used: Produced, Chromatography, Fractionation

    Specific antibody concentrations in intravenous immunoglobulin lots produced with and without the immunoaffinity chromatography step and in intermediates (‘feed’ and ‘flow-through’) of immunoaffinity chromatography
    Figure Legend Snippet: Specific antibody concentrations in intravenous immunoglobulin lots produced with and without the immunoaffinity chromatography step and in intermediates (‘feed’ and ‘flow-through’) of immunoaffinity chromatography

    Techniques Used: Produced, Chromatography, Concentration Assay

    Distribution of immunoglobulin G subclasses in intermediates (‘feed’) before immunoaffinity chromatography and final intravenous immunoglobulin product (‘bulk’)
    Figure Legend Snippet: Distribution of immunoglobulin G subclasses in intermediates (‘feed’) before immunoaffinity chromatography and final intravenous immunoglobulin product (‘bulk’)

    Techniques Used: Chromatography


    Figure Legend Snippet:

    Techniques Used: Chromatography, Produced

    Related Articles

    Purification:

    Article Title: Reduction of Isoagglutinin in Intravenous Immunoglobulin (IVIG) Using Blood Group A- and B-Specific Immunoaffinity Chromatography: Industry-Scale Assessment
    Article Snippet: .. To reduce the levels of isoagglutinins in a chromatographically purified IVIG product (Privigen ® , CSL Behring AG, Bern, Switzerland), an immunoaffinity chromatography (IAC) method was developed; this process was implemented on an industrial scale in 2015. ..

    Chromatography:

    Article Title: Reduction of Isoagglutinin in Intravenous Immunoglobulin (IVIG) Using Blood Group A- and B-Specific Immunoaffinity Chromatography: Industry-Scale Assessment
    Article Snippet: .. To reduce the levels of isoagglutinins in a chromatographically purified IVIG product (Privigen ® , CSL Behring AG, Bern, Switzerland), an immunoaffinity chromatography (IAC) method was developed; this process was implemented on an industrial scale in 2015. ..



    Similar Products

    chromatographically purified ivig product privigen  (CSL Behring)
    90
    CSL Behring chromatographically purified ivig product privigen
    Original and modified processes for the manufacture of the intravenous immunoglobulin <t>product,</t> <t>Privigen.</t> a When assessing the clearance of immunoglobulin M isoagglutinins by the anion-exchange chromatography and immunoaffinity chromatography steps, the process steps outlined in orange (ethanol- and octanoic acid fractionation) were omitted to minimize the loss of immunoglobulin M, and therefore the loss of the immunoglobulin M isoagglutinins. This was done because the octanoic acid fractionation step is the main elimination step of total immunoglobulin M. The intention was to retain as much immunoglobulin M as possible for the subsequent isoagglutinin removal steps. AIC immunoaffinity chromatography, AIEX anion exchange chromatography, DF diafiltration, UF ultrafitration. Adapted with permission from Hoefferer et al. © 2015 AABB. Hoefferer L, Glauser I, Gaida A, Willimann K, Marques Antunes A, Siani B, et al. Isoagglutinin reduction by a dedicated immunoaffinity chromatography step in the manufacturing process of human immunoglobulin products. Transfusion. 2015;55(Suppl 2):S117–21. doi:10.1111/trf.13088
    Chromatographically Purified Ivig Product Privigen, supplied by CSL Behring, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/chromatographically+purified+ivig+product+privigen/chromatographically+purified+ivig+product+privigen/pmc05054059-58-10-15
    Average 90 stars, based on 1 article reviews
    chromatographically purified ivig product privigen - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Original and modified processes for the manufacture of the intravenous immunoglobulin product, Privigen. a When assessing the clearance of immunoglobulin M isoagglutinins by the anion-exchange chromatography and immunoaffinity chromatography steps, the process steps outlined in orange (ethanol- and octanoic acid fractionation) were omitted to minimize the loss of immunoglobulin M, and therefore the loss of the immunoglobulin M isoagglutinins. This was done because the octanoic acid fractionation step is the main elimination step of total immunoglobulin M. The intention was to retain as much immunoglobulin M as possible for the subsequent isoagglutinin removal steps. AIC immunoaffinity chromatography, AIEX anion exchange chromatography, DF diafiltration, UF ultrafitration. Adapted with permission from Hoefferer et al. © 2015 AABB. Hoefferer L, Glauser I, Gaida A, Willimann K, Marques Antunes A, Siani B, et al. Isoagglutinin reduction by a dedicated immunoaffinity chromatography step in the manufacturing process of human immunoglobulin products. Transfusion. 2015;55(Suppl 2):S117–21. doi:10.1111/trf.13088

    Journal: Biodrugs

    Article Title: Reduction of Isoagglutinin in Intravenous Immunoglobulin (IVIG) Using Blood Group A- and B-Specific Immunoaffinity Chromatography: Industry-Scale Assessment

    doi: 10.1007/s40259-016-0192-3

    Figure Lengend Snippet: Original and modified processes for the manufacture of the intravenous immunoglobulin product, Privigen. a When assessing the clearance of immunoglobulin M isoagglutinins by the anion-exchange chromatography and immunoaffinity chromatography steps, the process steps outlined in orange (ethanol- and octanoic acid fractionation) were omitted to minimize the loss of immunoglobulin M, and therefore the loss of the immunoglobulin M isoagglutinins. This was done because the octanoic acid fractionation step is the main elimination step of total immunoglobulin M. The intention was to retain as much immunoglobulin M as possible for the subsequent isoagglutinin removal steps. AIC immunoaffinity chromatography, AIEX anion exchange chromatography, DF diafiltration, UF ultrafitration. Adapted with permission from Hoefferer et al. © 2015 AABB. Hoefferer L, Glauser I, Gaida A, Willimann K, Marques Antunes A, Siani B, et al. Isoagglutinin reduction by a dedicated immunoaffinity chromatography step in the manufacturing process of human immunoglobulin products. Transfusion. 2015;55(Suppl 2):S117–21. doi:10.1111/trf.13088

    Article Snippet: To reduce the levels of isoagglutinins in a chromatographically purified IVIG product (Privigen ® , CSL Behring AG, Bern, Switzerland), an immunoaffinity chromatography (IAC) method was developed; this process was implemented on an industrial scale in 2015.

    Techniques: Modification, Chromatography, Fractionation, Diafiltration Assay

    Anti-A and anti-B titers in intravenous immunoglobulin lots produced with the immunoaffinity chromatography step (Privigen) and intravenous immunoglobulin lots produced using Cohn-like fractionation (Sandoglobulin/Carimune), measured by the European Pharmacopoeia direct method. IAC immunoaffinity chromatography, IgG immunoglobulin G, IVIG intravenous immunoglobulin

    Journal: Biodrugs

    Article Title: Reduction of Isoagglutinin in Intravenous Immunoglobulin (IVIG) Using Blood Group A- and B-Specific Immunoaffinity Chromatography: Industry-Scale Assessment

    doi: 10.1007/s40259-016-0192-3

    Figure Lengend Snippet: Anti-A and anti-B titers in intravenous immunoglobulin lots produced with the immunoaffinity chromatography step (Privigen) and intravenous immunoglobulin lots produced using Cohn-like fractionation (Sandoglobulin/Carimune), measured by the European Pharmacopoeia direct method. IAC immunoaffinity chromatography, IgG immunoglobulin G, IVIG intravenous immunoglobulin

    Article Snippet: To reduce the levels of isoagglutinins in a chromatographically purified IVIG product (Privigen ® , CSL Behring AG, Bern, Switzerland), an immunoaffinity chromatography (IAC) method was developed; this process was implemented on an industrial scale in 2015.

    Techniques: Produced, Chromatography, Fractionation

    Specific antibody concentrations in intravenous immunoglobulin lots produced with and without the immunoaffinity chromatography step and in intermediates (‘feed’ and ‘flow-through’) of immunoaffinity chromatography

    Journal: Biodrugs

    Article Title: Reduction of Isoagglutinin in Intravenous Immunoglobulin (IVIG) Using Blood Group A- and B-Specific Immunoaffinity Chromatography: Industry-Scale Assessment

    doi: 10.1007/s40259-016-0192-3

    Figure Lengend Snippet: Specific antibody concentrations in intravenous immunoglobulin lots produced with and without the immunoaffinity chromatography step and in intermediates (‘feed’ and ‘flow-through’) of immunoaffinity chromatography

    Article Snippet: To reduce the levels of isoagglutinins in a chromatographically purified IVIG product (Privigen ® , CSL Behring AG, Bern, Switzerland), an immunoaffinity chromatography (IAC) method was developed; this process was implemented on an industrial scale in 2015.

    Techniques: Produced, Chromatography, Concentration Assay

    Distribution of immunoglobulin G subclasses in intermediates (‘feed’) before immunoaffinity chromatography and final intravenous immunoglobulin product (‘bulk’)

    Journal: Biodrugs

    Article Title: Reduction of Isoagglutinin in Intravenous Immunoglobulin (IVIG) Using Blood Group A- and B-Specific Immunoaffinity Chromatography: Industry-Scale Assessment

    doi: 10.1007/s40259-016-0192-3

    Figure Lengend Snippet: Distribution of immunoglobulin G subclasses in intermediates (‘feed’) before immunoaffinity chromatography and final intravenous immunoglobulin product (‘bulk’)

    Article Snippet: To reduce the levels of isoagglutinins in a chromatographically purified IVIG product (Privigen ® , CSL Behring AG, Bern, Switzerland), an immunoaffinity chromatography (IAC) method was developed; this process was implemented on an industrial scale in 2015.

    Techniques: Chromatography

    Journal: Biodrugs

    Article Title: Reduction of Isoagglutinin in Intravenous Immunoglobulin (IVIG) Using Blood Group A- and B-Specific Immunoaffinity Chromatography: Industry-Scale Assessment

    doi: 10.1007/s40259-016-0192-3

    Figure Lengend Snippet:

    Article Snippet: To reduce the levels of isoagglutinins in a chromatographically purified IVIG product (Privigen ® , CSL Behring AG, Bern, Switzerland), an immunoaffinity chromatography (IAC) method was developed; this process was implemented on an industrial scale in 2015.

    Techniques: Chromatography, Produced